![Novel fibroblast growth factor receptor 3 (FGFR3) mutations in bladder cancer previously identified in non-lethal skeletal disorders | European Journal of Human Genetics Novel fibroblast growth factor receptor 3 (FGFR3) mutations in bladder cancer previously identified in non-lethal skeletal disorders | European Journal of Human Genetics](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fsj.ejhg.5200883/MediaObjects/41431_2002_Article_BF5200883_Fig1_HTML.jpg)
Novel fibroblast growth factor receptor 3 (FGFR3) mutations in bladder cancer previously identified in non-lethal skeletal disorders | European Journal of Human Genetics
![Novel fibroblast growth factor receptor 3 (FGFR3) mutations in bladder cancer previously identified in non-lethal skeletal disorders | European Journal of Human Genetics Novel fibroblast growth factor receptor 3 (FGFR3) mutations in bladder cancer previously identified in non-lethal skeletal disorders | European Journal of Human Genetics](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fsj.ejhg.5200883/MediaObjects/41431_2002_Article_BF5200883_Fig2_HTML.jpg)
Novel fibroblast growth factor receptor 3 (FGFR3) mutations in bladder cancer previously identified in non-lethal skeletal disorders | European Journal of Human Genetics
Meclozine Facilitates Proliferation and Differentiation of Chondrocytes by Attenuating Abnormally Activated FGFR3 Signaling in Achondroplasia | PLOS ONE
![An FGFR3/MYC positive feedback loop provides new opportunities for targeted therapies in bladder cancers | EMBO Molecular Medicine An FGFR3/MYC positive feedback loop provides new opportunities for targeted therapies in bladder cancers | EMBO Molecular Medicine](https://www.embopress.org/cms/asset/f6482b0b-2f03-420f-85eb-31beaa44cf5d/emmm201708163-abs-0001-m.jpg)
An FGFR3/MYC positive feedback loop provides new opportunities for targeted therapies in bladder cancers | EMBO Molecular Medicine
![FGFR3 targeting strategies for achondroplasia | Expert Reviews in Molecular Medicine | Cambridge Core FGFR3 targeting strategies for achondroplasia | Expert Reviews in Molecular Medicine | Cambridge Core](https://static.cambridge.org/binary/version/id/urn:cambridge.org:id:binary-alt:20160626072936-25152-mediumThumb-S146239941200004X_fig3g.jpg?pub-status=live)
FGFR3 targeting strategies for achondroplasia | Expert Reviews in Molecular Medicine | Cambridge Core
![Achondroplasia with the FGFR3 1138g→a (G380R) mutation in two sibs sharing a 4p haplotype derived from their unaffected father | Journal of Medical Genetics Achondroplasia with the FGFR3 1138g→a (G380R) mutation in two sibs sharing a 4p haplotype derived from their unaffected father | Journal of Medical Genetics](https://jmg.bmj.com/content/jmedgenet/37/12/958/F2.large.jpg)